John D. Diekman, 10% Owner at Skye Bioscience, Inc. (SKYE), bought 10,412,148 shares at $2.31 ($24.1M) on 2024-01-31, disclosed to the SEC on 2024-02-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.31 | 5,206,074 | $12.0M | 50.0% |
| 2 | $2.31 | 5,206,074 | $12.0M | 50.0% |
| Total | $2.31 avg | 10,412,148 | $24.1M | 100% |
| Filing → |
| ZLAB | SELL | 2021-11-08 | $92K | — | Filing → |
| ZLAB | SELL | 2021-08-05 | $150K | — | Filing → |
| ZLAB | SELL | 2021-05-06 | $154K | — | Filing → |